Key predictors of attending hospital with COVID19: An association study from the COVID Symptom Tracker App in 2,618,948 individuals
暂无分享,去创建一个
Marc Modat | M. Jorge Cardoso | Sebastien Ourselin | Mario Falchi | Alessia Visconti | Thomas Varsavsky | Carole H. Sudre | Tim D. Spector | Joan Capdevila Pujol | David A. Drew | Richard Davies | Claire J. Steves | Sajaysurya Ganesh | Jonathan Wolf | T. Spector | C. Steves | M. Modat | S. Ourselin | T. Varsavsky | C. Sudre | M. Cardoso | J. C. Pujol | M. Falchi | C. Menni | D. Drew | L. Nguyen | J. Wolf | M. Freidin | S. Ganesh | A. Visconti | R. Bowyer | R. Davies | J. Moustafa | M. Graham | Cristina Menni | Maxim B. Freidin | Long H. Nguyen | Ruth C. E. Bowyer | Mark S Graham | Mary Ni Lochlainn | Julia S El-Sayed Moustafa | M. N. Lochlainn | KarlaA Lee | Julien Lavigne du Cadet | B. Murray | Xinyuan Zhang | Andrew T. Chan | Karla A. Lee | Benjamin Murray | Xinyuan Zhang | Andrew T. Chan | Thomas Varsavsky | J. E. Moustafa
[1] S. Ng,et al. Severe acute respiratory syndrome: prognostic implications of chest radiographic findings in 52 patients. , 2004, Radiology.
[2] S. Sethi,et al. Infection as a comorbidity of COPD , 2010, European Respiratory Journal.
[3] R. Perng,et al. Clinical Features and Outcomes of Severe Acute Respiratory Syndrome and Predictive Factors for Acute Respiratory Distress Syndrome , 2005, Journal of the Chinese Medical Association.
[4] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[5] Elizabeth Rea,et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. , 2003, JAMA.
[6] R. Pollock,et al. An investigation into the relationship between age and physiological function in highly active older adults , 2015, The Journal of physiology.
[7] William W Busse,et al. Role of viral respiratory infections in asthma and asthma exacerbations , 2010, The Lancet.
[8] Saxon Ridley. Critical care. , 2003, Anaesthesia.
[9] G. Lippi,et al. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19) , 2020, Respiratory Medicine.
[10] D. Aw,et al. Immunosenescence: emerging challenges for an ageing population , 2007, Immunology.
[11] K. Kawai,et al. Systematic review of incidence and complications of herpes zoster: towards a global perspective , 2014, BMJ Open.
[12] B. Weinberger. Vaccines for the elderly: current use and future challenges , 2018, Immunity & Ageing.
[13] Lei Dong,et al. Kidney disease is associated with in-hospital death of patients with COVID-19 , 2020, Kidney International.
[14] Wei Liu,et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province , 2020, Chinese medical journal.
[15] Jing Yuan,et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury , 2020, Science China Life Sciences.
[16] R. Kelishadi,et al. Health impacts of Obesity , 2014, Pakistan journal of medical sciences.
[17] L. Rosella,et al. Obesity and Respiratory Hospitalizations During Influenza Seasons in Ontario, Canada: A Cohort Study , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Jian Chen,et al. COVID‐19 infection may cause ketosis and ketoacidosis , 2020, Diabetes, obesity & metabolism.
[19] Jonathan H. Chung,et al. Essentials for Radiologists on COVID-19: An Update—Radiology Scientific Expert Panel , 2020, Radiology.
[20] A. Akbari,et al. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis , 2020, Archives of academic emergency medicine.
[21] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[22] W. Dietz,et al. Obesity and its Implications for COVID‐19 Mortality , 2020, Obesity.
[23] K Kroenke,et al. Gender Differences in the Reporting of Physical and Somatoform Symptoms , 1998, Psychosomatic medicine.
[24] C. Akdis,et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.
[25] Karl-Heinz Ladwig,et al. Gender differences of symptom reporting and medical health care utilization in the German population , 2000, European Journal of Epidemiology.
[26] Peter Cameron,et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.
[27] Akhtar Hussain,et al. COVID-19 and diabetes: Knowledge in progress , 2020, Diabetes Research and Clinical Practice.
[28] S. Zhang,et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series , 2020, BMJ.
[29] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[30] Kai Liu,et al. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients , 2020, Journal of Infection.
[31] L. Ferrucci,et al. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty , 2018, Nature Reviews Cardiology.
[32] Cdc Covid- Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 — United States, February 12–March 28, 2020 , 2020 .
[33] Q. Tao,et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases , 2020, Radiology.
[34] M. Beck,et al. Micronutrients, immunology and inflammation The impact of obesity on the immune response to infection , 2016 .
[35] Fanxin Zeng,et al. Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China , 2020, medRxiv.
[36] Lei Dong,et al. Kidney impairment is associated with in-hospital death of COVID-19 patients , 2020, medRxiv.
[37] G. Lippi,et al. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection , 2020, International Urology and Nephrology.
[38] T. Spector,et al. Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection , 2020, medRxiv.
[39] W. Liang,et al. Clinical characteristics of 2019 novel coronavirus infection in China , 2020, medRxiv.
[40] Tim D. Spector,et al. Rapid implementation of mobile technology for real-time epidemiology of COVID-19 , 2020, Science.
[41] R. Grassi‐Oliveira,et al. Features of Immunosenescence in Women Newly Diagnosed With Breast Cancer , 2018, Front. Immunol..
[42] M. He,et al. [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV]. , 2020, Zhonghua xin xue guan bing za zhi.
[43] Linda Partridge,et al. Ageing as a Risk Factor for Disease , 2012, Current Biology.
[44] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[45] Zhaofeng Chen,et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.
[46] Emily N. Ussery,et al. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[47] M. Falagas,et al. Obesity and infection. , 2006, The Lancet. Infectious diseases.
[48] R. Kennedy,et al. Personalized vaccinology: A review , 2017, Vaccine.
[49] S. Jaber,et al. ARDS in Obese Patients: Specificities and Management , 2019, Critical Care.
[50] Ting Yu,et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.
[51] Rui Ji,et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.
[52] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[53] D. Halpin,et al. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? , 2020, The Lancet Respiratory Medicine.
[54] Wei Xu,et al. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.